inclacumab (106)

Structure	 

Heavy chain / Chaone lourde / Cadena pesada

EVQLVESGGG LVRPGGSLRL SCAASGFTFS NYDMHWVRQA TGKGLEWVSA  50

ITAAGDIYYP GSVKGRFTIS RENAKNSLYL QMNSLRAGDT AVYYCARGRY 100

SGSGSYYNDW FDPWGQGTLV TVSSASTKGP SVFPLAPCSR STSESTAALG 150

CLVKDYFPEP VTVSWNSGAL TSGVHTFPAV LQSSGLYSLS SVVTVPSSSL 200

GTKTYTCNVD HKPSNTKVDK RVESKYGPPC PPCPAPEFEG GPSVFLFPPK 250

PKDTLMISRT PEVTCVVVDV SQEDPEVQFN WYVDGVEVHN AKTKPREEQF 300

NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK GLPSSIEKTI SKAKGQPREP 350

QVYTLPPSQE EMTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP 400

VLDSDGSFFL YSRLTVDKSR WQEGNVFSCS VMHEALHNHY TQKSLSLSLG 450

K                                                      451

Light chain / Chaone lygire / Cadena ligera

EIVLTQSPAT LSLSPGERAT LSCRASQSVS SYLAWYQQKP GQAPRLLIYD  50

ASNRATGIPA RFSGSGSGTD FTLTISSLEP EDFAVYYCQQ RSNWPLTFGG 100

GTKVEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV 150

DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG 200

LSSPVTKSFN RGEC                                        214

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	22-95	151-207	265-325	371-429

	22??-95??	151??-207??	265??-325??	371??-429??

Intra-L	23?-88?	134?-194?



	23???-88???	134???-194???



Inter-H-L	138-214?	138??-214???



Inter-H-H	230-230??	233-233??





N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

301, 301??

	

WHO 

International Nonproprietary Names Programme	

15/01/2012

9512

		

